Logo image of CRBD

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Stock Fundamental Analysis

NYSE:CRBD - US21871X2080

24.7 USD
-0.28 (-1.12%)
Last: 8/26/2025, 7:24:14 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CRBD. CRBD was compared to 100 industry peers in the Financial Services industry. CRBD may be in some trouble as it scores bad on both profitability and health. CRBD scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CRBD had positive earnings in the past year.
In the past year CRBD had a positive cash flow from operations.
CRBD had positive earnings in each of the past 5 years.
CRBD had a positive operating cash flow in each of the past 5 years.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

Looking at the Return On Assets, with a value of -0.08%, CRBD is doing worse than 74.00% of the companies in the same industry.
CRBD's Return On Equity of -2.74% is on the low side compared to the rest of the industry. CRBD is outperformed by 79.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.20%, CRBD is doing worse than 69.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRBD is significantly below the industry average of 7.71%.
Industry RankSector Rank
ROA -0.08%
ROE -2.74%
ROIC 0.2%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

In the last couple of years the Profit Margin of CRBD has grown nicely.
Looking at the Operating Margin, with a value of 7.02%, CRBD is doing worse than 62.00% of the companies in the same industry.
CRBD's Operating Margin has improved in the last couple of years.
The Profit Margin and Gross Margin are not available for CRBD so they could not be analyzed.
Industry RankSector Rank
OM 7.02%
PM (TTM) N/A
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRBD is destroying value.
The number of shares outstanding for CRBD has been reduced compared to 1 year ago.
The number of shares outstanding for CRBD has been reduced compared to 5 years ago.
Compared to 1 year ago, CRBD has a worse debt to assets ratio.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

CRBD has a debt to FCF ratio of 6.76. This is a slightly negative value and a sign of low solvency as CRBD would need 6.76 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.76, CRBD is in the better half of the industry, outperforming 63.00% of the companies in the same industry.
CRBD has a Debt/Equity ratio of 0.92. This is a neutral value indicating CRBD is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.92, CRBD perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.76
Altman-Z N/A
ROIC/WACC0.03
WACC7.51%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.75% over the past year.
The Earnings Per Share has been growing by 115.54% on average over the past years. This is a very strong growth
Looking at the last year, CRBD shows a very negative growth in Revenue. The Revenue has decreased by -16.47% in the last year.
CRBD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.01% yearly.
EPS 1Y (TTM)18.75%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%20.35%
Revenue 1Y (TTM)-16.47%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%5.84%

3.2 Future

Based on estimates for the next years, CRBD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.21% on average per year.
Based on estimates for the next years, CRBD will show a small growth in Revenue. The Revenue will grow by 3.39% on average per year.
EPS Next Y4.1%
EPS Next 2Y8.75%
EPS Next 3Y11.33%
EPS Next 5Y10.21%
Revenue Next Year-6.84%
Revenue Next 2Y-1.83%
Revenue Next 3Y-0.48%
Revenue Next 5Y3.39%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

CRBD is valuated cheaply with a Price/Earnings ratio of 4.81.
Compared to the rest of the industry, the Price/Earnings ratio of CRBD indicates a rather cheap valuation: CRBD is cheaper than 95.00% of the companies listed in the same industry.
CRBD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.08.
A Price/Forward Earnings ratio of 4.32 indicates a rather cheap valuation of CRBD.
Based on the Price/Forward Earnings ratio, CRBD is valued cheaper than 94.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CRBD to the average of the S&P500 Index (22.67), we can say CRBD is valued rather cheaply.
Industry RankSector Rank
PE 4.81
Fwd PE 4.32
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CRBD's Enterprise Value to EBITDA is on the same level as the industry average.
CRBD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRBD is cheaper than 82.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.93
EV/EBITDA 18.65
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.18
PEG (5Y)0.04
EPS Next 2Y8.75%
EPS Next 3Y11.33%

More info and screens

2

5. Dividend

5.1 Amount

CRBD has a Yearly Dividend Yield of 2.81%. Purely for dividend investing, there may be better candidates out there.
CRBD's Dividend Yield is a higher than the industry average which is at 4.27.
CRBD's Dividend Yield is a higher than the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

CRBD does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of CRBD are negative and hence is the payout ratio. CRBD will probably not be able to sustain this dividend level.
DP-156.08%
EPS Next 2Y8.75%
EPS Next 3Y11.33%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

More info and screens

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (8/26/2025, 7:24:14 PM)

24.7

-0.28 (-1.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners92.72%
Inst Owner ChangeN/A
Ins Owners0.34%
Ins Owner ChangeN/A
Market Cap13.30B
Analysts79.05
Price Target30.6 (23.89%)
Short Float %0.01%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP-156.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.55%
Min EPS beat(2)-0.44%
Max EPS beat(2)15.55%
EPS beat(4)3
Avg EPS beat(4)7.91%
Min EPS beat(4)-0.44%
Max EPS beat(4)15.87%
EPS beat(8)6
Avg EPS beat(8)4.91%
EPS beat(12)10
Avg EPS beat(12)8.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.67%
Min Revenue beat(2)-11.92%
Max Revenue beat(2)-11.42%
Revenue beat(4)0
Avg Revenue beat(4)-14.95%
Min Revenue beat(4)-21.6%
Max Revenue beat(4)-11.42%
Revenue beat(8)2
Avg Revenue beat(8)-15.15%
Revenue beat(12)4
Avg Revenue beat(12)-7.57%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.76%
PT rev (3m)9.56%
EPS NQ rev (1m)-2.91%
EPS NQ rev (3m)-10.18%
EPS NY rev (1m)1.75%
EPS NY rev (3m)-0.88%
Revenue NQ rev (1m)-4.89%
Revenue NQ rev (3m)-12.4%
Revenue NY rev (1m)-5.77%
Revenue NY rev (3m)-7.82%
Valuation
Industry RankSector Rank
PE 4.81
Fwd PE 4.32
P/S 0.91
P/FCF 7.93
P/OCF 7.93
P/B 1.08
P/tB 1.08
EV/EBITDA 18.65
EPS(TTM)5.13
EY20.77%
EPS(NY)5.72
Fwd EY23.17%
FCF(TTM)3.12
FCFY12.62%
OCF(TTM)3.12
OCFY12.62%
SpS27.22
BVpS22.85
TBVpS22.85
PEG (NY)1.18
PEG (5Y)0.04
Profitability
Industry RankSector Rank
ROA -0.08%
ROE -2.74%
ROCE 0.26%
ROIC 0.2%
ROICexc 0.2%
ROICexgc 0.3%
OM 7.02%
PM (TTM) N/A
GM N/A
FCFM 11.45%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
ROICexc(3y)1.09%
ROICexc(5y)0.99%
ROICexgc(3y)1.62%
ROICexgc(5y)1.5%
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexcg growth 3Y-24.91%
ROICexcg growth 5YN/A
ROICexc growth 3Y-23.75%
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.76
Debt/EBITDA 8.67
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.78
Cash Conversion 128.19%
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.51%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)18.75%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%20.35%
EPS Next Y4.1%
EPS Next 2Y8.75%
EPS Next 3Y11.33%
EPS Next 5Y10.21%
Revenue 1Y (TTM)-16.47%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%5.84%
Revenue Next Year-6.84%
Revenue Next 2Y-1.83%
Revenue Next 3Y-0.48%
Revenue Next 5Y3.39%
EBIT growth 1Y-41.6%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next Year-7.21%
EBIT Next 3Y0.32%
EBIT Next 5YN/A
FCF growth 1Y-55.04%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-55.04%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%